Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study


Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has been well documented, there is a paucity of clinical data regarding the safety and tolerance of propranolol in neonates. A prospective study of 51 patients less than 30 days of age with severe IH was conducted. All patients were admitted to the hospital for monitoring… (More)
DOI: 10.1038/s41598-017-01321-2


9 Figures and Tables

Slides referencing similar topics